# Partnership Brief: Neuralink - Phyllux Mesh for Brain-Computer Interfaces

**Status:** âœ… Ready to send (pending PPA filing)  
**Tier:** Pioneer (Tier 1)  
**Technology:** Phyllux Mesh + Brain-Computer Interfaces  
**Fusion:** 234  
**Priority:** ðŸ”´ URGENT

---

## Executive Summary

Phyllux Mesh, a phyllotactic neural meshing technology using non-periodic electrode arrays, may provide significant advantages for Neuralink's brain-computer interface (BCI) systems. Our 121-electrode phyllotactic layout is designed to minimize crosstalk between channels and may improve signal quality compared to regular grid arrays.

**Key Advantages:**
- Non-periodic electrode spacing may reduce crosstalk
- Scalable Fibonacci-based counts (13, 21, 34, 55, 89, 121, 144, etc.)
- Public prior art established (January 7, 2026)
- PPA filing in progress (late January 2026)

---

## Technology Overview

### Phyllux Mesh (Phyllotactic Neural Meshing)

**Core Innovation:**
- Electrode arrays using phyllotactic spacing with golden angle (137.508Â°)
- Non-periodic layouts designed to minimize crosstalk
- Fibonacci-based element counts for optimal spacing

**Technical Evidence:**
- Public code: [biomimetic-inventions-public/PNM-public/](https://github.com/phibronotchi-beep/biomimetic-inventions-public/tree/main/PNM-public)
- Simulation results: Crosstalk reduction, signal-to-noise ratio improvements
- Technical figures: 121-electrode layout, spatial sampling uniformity
- Prior art: January 7, 2026 (first commit)

**Maturity:**
- Structural (7/10) - Detailed specifications, simulation results
- Ready for in-vivo validation
- PPA filing in progress

---

## Application to Neuralink BCIs

### Potential Benefits

**Crosstalk Reduction:**
- Non-periodic electrode spacing may reduce crosstalk between channels
- Simulations suggest improved signal isolation
- May enable higher channel counts with maintained signal quality

**Signal Quality:**
- Spatial sampling uniformity may improve signal acquisition
- Signal-to-noise ratio improvements suggested by simulations
- 3D electrode arrays with depth variation for optimal placement

**Scalability:**
- Fibonacci-based counts (13, 21, 34, 55, 89, 121, 144, etc.)
- Scalable to various electrode counts
- Algorithm works for 10-1000+ electrodes

### Technical Validation

**Public Code:**
- Reproducible Python implementations
- MIT licensed (free for research)
- Available at: [biomimetic-inventions-public/PNM-public/](https://github.com/phibronotchi-beep/biomimetic-inventions-public/tree/main/PNM-public)

**Simulation Results:**
- Crosstalk minimization analysis
- Signal-to-noise ratio improvements
- Spatial sampling uniformity comparisons
- 3D electrode array depth variation

**Figures for Review:**
- Figure 1: 121-electrode phyllotactic layout
- Figure 5: Crosstalk minimization analysis
- Figure 9: Signal-to-noise ratio improvement
- Figure 11: 3D electrode array with depth variation
- Figure 14: Spatial sampling uniformity comparison

---

## Mission Alignment

**Neuralink's Mission:**
- Restore human capability
- Enable communication for people with paralysis
- Advance brain-computer interface technology

**Phyllux Alignment:**
- Technology designed to improve BCI signal quality
- May enable better neural interfaces for medical applications
- Supports Neuralink's mission to restore human capability
- Ethical licensing framework (see phyllux-framework)

---

## Licensing Framework

**Tier 1: Pioneer (Exclusive Potential)**
- Exclusive or semi-exclusive licensing
- Mission-critical applications
- High-value partnerships
- Strategic collaboration

**Proposed Terms:**
- Upfront license fee: $10-20M
- Annual royalties: 2-5% of revenue
- Milestone payments: $2-10M per major milestone
- Equity (optional): 1-5% equity stake

**Terms are negotiable** based on partnership structure and exclusivity scope.

---

## Next Steps

1. **Technical Discussion:**
   - Review technical validation data
   - Discuss in-vivo validation planning
   - Explore integration opportunities

2. **Licensing Discussion:**
   - Review licensing framework
   - Discuss exclusivity terms
   - Negotiate partnership structure

3. **Timeline:**
   - PPA filing: Late January 2026
   - Technical validation: 12-24 months
   - First commercial deployment: 18-36 months

---

## Contact Information

**David Edward Sproule**  
Independent Inventor | Phyllux Technologies  
Alberta, Canada  
Email: phibronotchi@gmail.com

**Public Repositories:**
- Framework & Licensing: [phyllux-framework](https://github.com/phibronotchi-beep/phyllux-framework)
- Public Demonstrations: [biomimetic-inventions-public](https://github.com/phibronotchi-beep/biomimetic-inventions-public)
- Fusion Embodiments: [phyllux-inventions-wip](https://github.com/phibronotchi-beep/phyllux-inventions-wip)

---

## Important Notes

**Qualified Language:**
- All performance claims use qualified language ("may", "designed to", "simulations suggest")
- No absolute guarantees or performance assertions
- Maturity framework indicates development stage

**Prior Art:**
- Public prior art established January 7, 2026
- PPA filing in progress (late January 2026)
- Defensive publication strategy protects against IP threats

**Ethical Boundaries:**
- Technology available for medical and research applications
- Ethical licensing framework (see phyllux-framework)
- Mission-aligned partnerships prioritized

---

**Last Updated:** January 25, 2026  
**Status:** âœ… Ready to send (pending PPA filing)
